Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-center Evaluation of Sleepiz One+ Algorithm in Estimating Respiration Rate and Heart Rate Compared to Gold Standard

NCT06569940 is registered in ClinicalTrials.gov with Sleepiz AG as lead sponsor.

NCT NCT06569940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06569940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-center Evaluation of Sleepiz One+ Algorithm in Estimating Respiration Rate and Heart Rate Compared to Gold Standard
Lead sponsor
Sleepiz AG
Phase
Not applicable
Overall status
Recruiting
Start date
July 18, 2024
Completion date
September 30, 2024
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, cardiovascular diseases, copd, diabetes, hypertension, respiratory disease, sleep apnea